Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Neusspray met CGRP-receptorantagonist werkzaam bij migraine
jun 2022 | Hoofdpijn